Beyond the Skin: Addressing the Drivers, Psychosocial Impact and Role of Goal Setting in Vitiligo Care
FREE NON-CME Dermatology Webinar
Tuesday, Sept 23, 2025 | 5:00 - 6:00 PM PDT
Mehdi Rashighi, MD
Erik Domingues, MD FAAD
Joanna L. Rosen, PsyD
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by AbbVie and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
This webinar will examine the psychosocial impact of vitiligo and examine how timely, individualized care can improve quality of life and patient outcomes.
Learning Objectives:
Understand the impact of the psychosocial burden of vitiligo on patients
Explore how strategies for timely and sustained clinical intervention could improve quality of life and optimize patient outcomes
Explore the importance of setting personalized treatment goals and expectations, tailored to individual patient needs and recognizing progress through meaningful goal achievement
Join us LIVE!
Brought to you by
ABBV-US-02401-E
Conversations in practice: A case-based approach to effective assessment and goal setting in alopecia areata care
FREE NON-CME Dermatology Webinar
Tuesday, November 11, 2025 | 5:00 - 6:00 PM PST
Dr. Carolyn Goh MD, FAAD
Dr. Meena Singh MD, FAAD
Dr. Jennifer Soung MD, FAAD
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by AbbVie and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
Explore alopecia areata (AA) from mechanism to management. Gain expert insights into the immune drivers, clinical presentations, and practical, patient-centered approaches that can enhance outcomes and quality of life.
Learning Objectives:
Recognize how the immune-mediated mechanisms of alopecia areata drive its presentation and progression
Understand the myriad nature of presentation and burden for patients with AA
Explore how comprehensive approaches to care can support optimized patient outcomes
Join us LIVE!
Brought to you by
ABBV-US-02401-E
Conversations in practice: A case-based approach to effective assessment and goal setting in alopecia areata care
FREE NON-CME Dermatology Webinar
Tuesday, November 11, 2025 | 5:00-6:00 PM PST
Carolyn Goh MD, FAAD
Meena Singh MD, FAAD
Jennifer Soung MD, FAAD
DAYS
HRS
MIN
SEC
This event is brought to you by Pendulum Therapeutics. This is not a congress-endorsed event and is not part of official programming for a congress. No CME credits will be given for attendance.
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Abbvie and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
Explore alopecia areata (AA) from mechanism to management. Gain expert insights into the immune drivers, clinical presentations, and practical, patient-centered approaches that can enhance outcomes and quality of life.
Learning Objectives:
Recognize how the immune-mediated mechanisms of alopecia areata drive its presentation and progression
Understand the myriad nature of presentation and burden for patients with AA
Explore how comprehensive approaches to care can support optimized patient outcomes
Discuss the various forms of stem cells that are found within the skin
Summarize the integrative approach to hair health and the role of growth factor based therapies
Evaluate the role of stem cell derived topical therapies for post-procedure care
Tailor post-procedure protocols to individual needs
Join us live!
Be part of the experience—gain valuable insights and real-time engagement!
Brought to you by
AbbVie Medical Affairs + Health Impact
ABBV-US-02514-E
Incyte and the Incyte logo are registered trademarks of Incyte
© 2025, Incyte. MAT-DRM-01633 03/25
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
Advancing Skin Science: The Role of Peptide Innovation in Modern Dermatology
FREE NON-CME Dermatology Webinar
Tuesday, August 4, 2026 | 5:00 PM - 6:00 PM PDT
Francesa Lewis, MD, FAAD
David Cotter, MD, PhD
Daniel Butler, MD
DAYS
HRS
MIN
SEC
This event is brought to you by Pendulum Therapeutics. This is not a congress-endorsed event and is not part of official programming for a congress. No CME credits will be given for attendance.
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Croda Beauty and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
Peptide science continues to evolve, creating new opportunities for innovation across dermatology and skincare. This session will explore emerging peptide technologies, advances in ingredient development, and the latest research shaping peptide-based formulations. Participants will gain a clearer understanding of how peptides function, the factors that influence their efficacy and stability, and their potential applications in supporting skin health, repair, and healthy aging. The session will also examine how ongoing advances in peptide delivery and formulation may influence future product development and clinical recommendations.
Learning Objectives:
Upon completion of this session, participants will be able to:
Describe the mechanisms by which peptides may support skin health, repair, and visible signs of aging.
Identify emerging peptide technologies and ingredient innovations influencing dermatologic and skincare product development.
Evaluate current research on the efficacy, safety, stability, and delivery of peptide-based formulations.
Differentiate among common peptide categories and their potential applications in dermatology and cosmetic skincare.
Discuss how advances in peptide science may inform future clinical recommendations, treatment strategies, and product selection.
Join us live!
Be part of the experience—gain valuable insights and real-time engagement!
Brought to you by
Mast Cell Diseases: Understanding the Spectrum of Disease, Signs, Symptoms and an Approach to Management
FREE NON-CME Dermatology Webinar
Tuesday, September 22, 2026 | 5:00 PM - 6:00 PM PDT
Sarina B. Elmariah, MD, PhD, MPH, FAAD
David Cotter, MD, PhD
Daniel Butler, MD
DAYS
HRS
MIN
SEC
This event is brought to you by Pendulum Therapeutics. This is not a congress-endorsed event and is not part of official programming for a congress. No CME credits will be given for attendance.
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Blueprint Medicines and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
Mast cell diseases encompass a spectrum of conditions that can present with a wide range of signs and symptoms, making recognition and diagnosis challenging. In this webinar, Dr. Sarina B. Elmariah will review the fundamentals of mast cell biology and explore key distinctions among cutaneous and systemic mastocytosis, mast cell activation syndrome, and hereditary α-tryptasemia. Attendees will learn how to recognize clinical presentations, differentiate between mast cell disorders, understand the diagnostic tests used in patient evaluation, and review key considerations for management.
Learning Objectives:
Review basic mast cell biology and mast cell mediators
Discuss and differentiate the signs and symptoms of distinct mast cell diseases, including cutaneous and systemic mastocytosis, mast cell activation syndrome and hereditary α-tryptasemia
Discuss diagnostic tests to identify patients with mast cell disease
Summarize considerations in the management of mast cell diseases
Join us live!
Be part of the experience—gain valuable insights and real-time engagement!
Brought to you by
The AI Advantage for Dermatology Practices: Everyday Workflows That Boost New Patients and Retention
FREE NON-CME Dermatology Webinar
Tuesday, March 24, 2026 | 5:00 PM - 6:00 PM PDT
Chad Erickson
Robert Antosy
Michael Antosy
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by MyAdvice and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
AI isn’t a futuristic add-on, it’s a practical way to grow a dermatology practice with less effort and better outcomes. In this panel discussion, three MyAdvice dermatology growth experts share what they see working daily across private derm practices: where AI-driven search and patient discovery are shifting, how simple automations turn interest into booked appointments, and which repeatable workflows protect retention without adding staff. We’ll reference the MyAdvice Success Center and Mya, our AI Growth Assistant, as examples of a system that compounds visibility, conversion, and efficiency over time, while keeping the focus on education and real-world takeaways you can apply right away. Best suited for practice owners and managing partners who want profitable growth, clear metrics, and less complexity in their marketing and operations.
Learning Objectives:
Segment 1: Evolving Therapies and Personalization (30 mins) - Michael G. Lewitt, MD
-Explore the current and emerging therapeutic landscape.
-Discuss biologic selection and treatment tailoring based on patient profiles.
-Introduce combination and sequencing strategies for moderate-to-severe PsO.
Segment 2: Systemic Implications and Whole-Patient Care (30 mins) - Tina Bhutani, MD MAS
-Address the links between psoriasis, cardiometabolic disease, and systemic inflammation.
-Review comorbidity screening and integrated care approaches.
-Highlight quality-of-life and long-term management considerations.
Gain perspectives from a patient living with vitiligo, to better understand the impact of disease and how to support shared decision-making
Understand the indicated patient population for treatment
Join us live!
Be part of the experience—gain valuable insights and real-time engagement!
Supported by
Brought to you by
Incyte and the Incyte logo are registered trademarks of Incyte
© 2025, Incyte. MAT-DRM-01633 03/25
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
A Product Theater for Taltz® and Zepbound® Injection Including an Affordability Solution for Eligible Taltz Patients Prescribed Zepbound
FREE NON-CME Dermatology Webinar
Live Event Only • No Recording Will Be Available
Tuesday, September 8, 2026 | 5:00 PM - 6:00 PM PDT
Saakshi Khattri MBBS, MD, FAAD, FACR
Tina Bhutani, MD MAS
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Lilly and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
ProgrAm Objective:
Beyond Skin and Joints: Concomitant Taltz (ixekizumab) and Zepbound (tirzepatide) for Adults with PsA/PsO and Obesity
-Explore the current and emerging therapeutic landscape.
-Discuss biologic selection and treatment tailoring based on patient profiles.
-Introduce combination and sequencing strategies for moderate-to-severe PsO.
Segment 2: Systemic Implications and Whole-Patient Care (30 mins) - Tina Bhutani, MD MAS
-Address the links between psoriasis, cardiometabolic disease, and systemic inflammation.
-Review comorbidity screening and integrated care approaches.
-Highlight quality-of-life and long-term management considerations.
Gain perspectives from a patient living with vitiligo, to better understand the impact of disease and how to support shared decision-making
Understand the indicated patient population for treatment
Join us live!
Be part of the experience—gain valuable insights and real-time engagement!
Supported by
Brought to you by
Incyte and the Incyte logo are registered trademarks of Incyte
© 2025, Incyte. MAT-DRM-01633 03/25
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
Expanding the Story in Moderate AD Patients With Higher Disease Severity
FREE NON-CME Dermatology Webinar
Tuesday, October 13, 2026 | 5:00 PM - 6:00 PM PDT
Diego Dasilva, MD
Tina Bhutani, MD MAS
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Incyte Corporation and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
Join us to review the prevalence of AD and considerations for managing adult patients with moderate disease.
Learning Objectives:
Review the prevalence of AD and considerations for managing adult patients with moderate disease
Understand the mechanism of action and formulation of OPZELURA and its indicated patient population
Evaluate the safety and efficacy data for OPZELURA in non-immunocompromised moderate AD patients with higher disease severity 18 years of age and older
Discuss the available patient support and access offerings to assist patients prescribed OPZELURA
Join us live!
Be part of the experience—gain valuable insights and real-time engagement!
Supported by
Brought to you by
Incyte and the Incyte logo are registered trademarks of Incyte
© 2025, Incyte. MAT-DRM-01633 03/25
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
Chronic Hand Eczema: A New Day Is at Hand
FREE NON-CME Dermatology Webinar
Tuesday, September 30, 2025 | 5:00 - 6:00 PM PDT
Lakshi M. Aldredge, MSN ANP-BC DCNP FAANP
Valerie Stern, DMSc MPAS PA-C
DAYS
HRS
MIN
SEC
Chronic hand eczema (CHE) can disrupt daily life and confidence. Explore the latest mechanisms behind CHE including immune pathways and barrier dysfunction and discover advanced treatments from topical breakthroughs to targeted systemic therapies. Learn practical strategies to personalize care, manage triggers, and empower patients to break the flare cycle for lasting relief.
Learning Objectives:
Describe the clinical presentation, epidemiology, and impact of chronic hand eczema on patients’ daily lives.
Differentiate the major subtypes of chronic hand eczema and understand their specific disease burdens.
Review the immunologic and barrier-related mechanisms underlying each CHE subtype and how these inform targeted therapies.
Apply evidence-based strategies for assessing disease severity and selecting appropriate treatment options, including topical, systemic, and emerging therapies.
Integrate knowledge of CHE pathophysiology, subtypes, and management into practical approaches to improve patient outcomes and quality of life.
Join us LIVE!
Be part of the experience—gain valuable insights and real-time engagement!
Brought to you by
A JAK inhibitor in Nonsegmental Vitiligo: Results of Two Phase 3 Randomized Controlled Studies (Viti-Up)
FREE NON-CME Dermatology Webinar
Tuesday, October 27, 2026 | 5:00 PM - 6:00 PM PDT
Erik Domingues, MD
Erika Page
DAYS
HRS
MIN
SEC
Please note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by AbbVie and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses, guests, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal, state or local laws or government ethics restrictions may not attend this event.
Efficacy and Safety of a JAK inhibitor in Adults and Adolescents for the Treatment of Nonsegmental Vitiligo: Results of Two Phase 3 Randomized Controlled Studies (Viti-Up)
Learning Objectives:
For HCPs to evaluate potential treatment options to support individualized treatment decisions for their patients with nonsegmental vitiligo.
Discuss the mechanism of action and formulation for a topical treatment option for nonsegmental vitiligo
Evaluate the safety and efficacy data for a topical treatment option in the treatment of nonsegmental vitiligo
Consider how to counsel patients and establish treatment expectations for patients with nonsegmental vitiligo
Join us live!
Be part of the experience—this webinar will not be recorded, so don’t miss out!
Brought to you by
AbbVie Medical Affairs + Health Impact
JAKa-US-00120-MC
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
EBGLYSS®(lebrikizumab-lbkz): What could less mean for your patients?
FREE NON-CME Dermatology Webinar
Tuesday, June 23, 2026 | 5:00 PM - 6:00 PM PDT
Tina Bhutani-Jacques, MD MAS FAAD
DAYS
HRS
MIN
SEC
This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.
Please see Prescribing Information and Patient Information at the product theater or on https://ebglyss.lilly.com.
Please see Instructions for Use included with the device.
EBGLYSS® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Join your colleagues for a peer discussion exploring the latest EBGLYSS data.
Learning Objectives:
Join an expert-led discussion on the pathophysiology of vitiligo, challenges in disease management, goals of therapy, and best practices for patient communication and shared decision-making
Gain perspectives from a patient living with vitiligo, to better understand the impact of disease and how to support shared decision-making
Understand the indicated patient population for treatment
Join us live!
Be part of the experience—this webinar will not be recorded, so don’t miss out!
Sponsored by
Brought to you by
Incyte and the Incyte logo are registered trademarks of Incyte
© 2025, Incyte. MAT-DRM-01633 03/25
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
For safety information, refer to the prescribing details below.
Explore EBGLYSS®(lebrikizumab-lbkz): See How EBGLYSS Can Leave a Lasting Impression
FREE NON-CME Dermatology Webinar
Tuesday, October 21, 2025 | 5:00 PM - 6:00 PM PDT
Edward (Ted) Lain, MD
DAYS
HRS
MIN
SEC
This event is brought to you by Eli Lilly and Company. This is not a congress-endorsed event and is not part of official programming for a congress. No CME credits will be given for attendance.
Join us for "Explore EBGLYSS® (lebrikizumab-lbkz)", an event where a clinician will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data, safety, dosing information, and real-world experience from patient cases.
Learning Objectives:
Understand the mechanism of action of lebrikizumab-lbkz in targeting IL-13
Review clinical trial data on the efficacy and safety of EBGLYSS™
Identify appropriate patient candidates for lebrikizumab-lbkz
Discuss strategies for integrating lebrikizumab-lbkz into clinical practice
Join us live! Be part of the experience—don’t miss out!
Sponsored by
Visit ADVENTprogram.com to discover more resources on prurigo nodularis and other diseases with underlying type 2 inflammation
MAT-US-2407348 – v1.0 – P Exp Date: 01/10/2025
SAFETY SUMMARY
Warnings – Do not use EBGLYSS if you are allergic to lebrikizumab-lbkz or to any of the ingredients in EBGLYSS. See the Patient Information leaflet that comes with EBGLYSS for a complete list of ingredients.
Before using
Before using EBGLYSS, tell your healthcare provider about all your medical conditions, including if you:
- Have a parasitic (helminth) infection.
- Are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with EBGLYSS.
- Are pregnant or plan to become pregnant. It is not known if EBGLYSS will harm your unborn baby. If you become pregnant during treatment with EBGLYSS, you or your healthcare provider can call Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) to report the pregnancy.
- Are breastfeeding or plan to breastfeed. It is not known if EBGLYSS passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Possible side effects
EBGLYSS can cause serious side effects, including:
- Allergic reactions. EBGLYSS can cause allergic reactions that may sometimes be severe. Stop using EBGLYSS and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms:
- breathing problems or wheezing
- swelling of the face, lips, mouth, tongue or throat
- hives
- itching
- fainting, dizziness, feeling lightheaded
- skin rash
- cramps in your stomach area (abdomen)
- Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision.
The most common side effects of EBGLYSS include:
- eye and eyelid inflammation, including redness, swelling, and itching
- injection site reactions
- shingles (herpes zoster)
These are not all of the possible side effects of EBGLYSS. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
How to take
- See the detailed “Instructions for Use” that comes with EBGLYSS for information about how to prepare and inject EBGLYSS and how to properly store and throw away (dispose of) used EBGLYSS prefilled pens and prefilled syringes.
- Use EBGLYSS exactly as prescribed by your healthcare provider.
- EBGLYSS is given as an injection under the skin (subcutaneous injection).
- If your healthcare provider decides that you or a caregiver can give the injections of EBGLYSS, you or a caregiver should receive training on the right way to prepare and inject EBGLYSS. Do not try to inject EBGLYSS until you have been shown the right way by your healthcare provider. In children 12 years of age and older, EBGLYSS should be given by a caregiver.
- If you miss a dose of EBGLYSS, inject the missed dose as soon as possible, then inject your next dose at your regular scheduled time.
Learn more
EBGLYSS is a prescription medicine available as a 250 mg/2 mL injection prefilled pen or prefilled syringe. For more information, call 1-800-545-5979 or go to ebglyss.lilly.com
This summary provides basic information about EBGLYSS but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking to your doctor. Be sure to talk to your doctor or other healthcare provider about EBGLYSS and how to take it. Your doctor is the best person to help you decide if EBGLYSS is right for you.
LK CON BS AD APP
INDICATION
EBGLYSS™ (EHB-glihs) is an injectable medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) with moderate-to-severe eczema (atopic dermatitis) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. EBGLYSS can be used with or without topical corticosteroids.
It is not known if EBGLYSS is safe and effective in children less than 12 years of age or in children 12 years to less than 18 years of age who weigh less than 88 pounds (40 kg).
UPCOMING MASTER CLASSES AND LIVE CME LECTURES
NON-CME
Modern Management of Alopecia Areata: Innovation Meets Compassion
December 16, 2025 | 5:00 PM - 6:00 PM PST
Paradi Mirmirani, MD
Jennifer Fu, MD
Live Non-CME
This comprehensive session explores alopecia areata through both scientific and clinical lenses, offering an in-depth review of the evolving understanding and management of this complex autoimmune condition. The first segment will examine the immunopathogenesis of alopecia areata and highlight key advances in targeted therapies, including emerging JAK inhibitors and biologic agents. The second segment will focus on the patient experience addressing the psychosocial impacts, communication strategies, and practical integration of new therapies into clinical practice. Participants will gain actionable insights for optimizing patient outcomes and implementing evidence-based, compassionate care.
Learning Objectives:
Segment 1: Immunopathogenesis and Treatment Innovation (30 mins)
- Discuss an overview of disease mechanisms and autoimmune targeting.
- Review current and emerging JAK inhibitor therapies.
- Discuss biologic rationale and trial data insights.
Segment 2: Patient Impact and Practice Integration (30 mins)
- Explore mental health impacts and patient-centered communication.
- Identify referral pathways and access considerations.
- Share case-based approaches to diagnosis and treatment planning.
Sponsored by Lilly and Abbvie
NON-CME
Expanding the Story in Moderate AD Patients With Higher Disease Severity
October 13, 2026 | 5:00 PM - 6:00 PM PDT
Diego Dasilva, MD
Robert Antosy
Chad Erickson
Live Non-CME Lecture
Join us to review the prevalence of AD and considerations for managing adult patients with moderate disease.
Learning Objectives:
- Review the prevalence of AD and considerations for managing adult patients with moderate disease
- Understand the mechanism of action and formulation of OPZELURA and its indicated patient population
- Evaluate the safety and efficacy data for OPZELURA in non-immunocompromised moderate AD patients with higher disease severity 18 years of age and older
- Discuss the available patient support and access offerings to assist patients prescribed OPZELURA
Brought to you by Incyte
NON-CME
From Gut to Skin: How Early-Life Microbiome Development Shapes the Atopic March
June 16, 2026 | 5:00 PM - 6:00 PM PdT
Danielle Shea Tan, MS, CHC, CNS, LDN
Tonia Vinton, MD
Wilson Liao, MD
Jennifer Pellegrin-Perez, DNP RN PHN DPCS
Live Non-CME Lecture
The relationship between gut microbiome composition and skin health is increasingly well-supported by research — yet translating this science into clinical practice remains a challenge for many practitioners. In this session, we build on foundational gut–skin axis knowledge to explore how early-life microbiome development shapes immune programming, establishes the trajectory for atopic disease and how these insights can be translated into clinical care.
Focusing on the atopic march — the progression from eczema in infancy through food allergies, allergic rhinitis, and asthma — this session explores how early microbial patterns influence immune tolerance, inflammation, and barrier function across the gut–skin axis. Particular attention is given to the role of Bifidobacterium in early immune education, the distinct microbiome signatures associated with birthing methods, and the downstream effects of common disruptors including formula feeding and antibiotic exposure. Research from the Infant Restore randomized controlled trial is presented as clinical evidence of how microbiome-guided interventions can recover the microbial community and improve gut-skin-immune outcomes for infants.
The session concludes by briefly extending these principles beyond infancy, emphasizing how shotgun metagenomic testing can be used to assess gut–skin-immune interactions and guide personalized care across all patient populations.
Learning Objectives:
By the end of this session, participants will be able to:
- Explain how early-life microbiome development influences immune programming and impacts skin health through the gut–skin axis
- Describe the atopic march and the role of early microbial patterns and disruptions in driving progression from eczema to allergic disease
- Identify key microbial features associated with atopic risk — including Bifidobacterium depletion and C-section-associated dysbiosis — and their effects on immune tolerance, inflammation, and barrier function
- Apply microbiome-informed strategies, including stool testing and targeted interventions, to assess and support patients with atopic and inflammatory skin conditions across the lifespan
Supported by Tiny Health
NON-CME
Obesity in Dermatology: Managing Metabolic Inflammation and Lifestyle Integration
January 6, 2026 | 5:00 PM - 6:00 PM PST
Raja Sivamani, MD MS AP
Jason Hawkes, MD MS
Erin Barrett, MD
Live Non-CME Lecture
This session explores the connection between adipose tissue, systemic inflammation, and their downstream effects on dermatologic disease, highlighting key metabolic pathways that influence skin outcomes. Faculty will also introduce incretin-based therapies and discuss their emerging relevance in inflammatory skin conditions. Building on this foundation, the session provides practical, time-efficient strategies for initiating lifestyle conversations in busy dermatology settings, with examples of achievable diet and exercise recommendations. Participants will leave with actionable approaches for integrating lifestyle interventions into comprehensive dermatologic care plans.
Learning Objectives:
Segment 1: Inflammation, Weight, and Dermatologic Outcomes (30 mins)
- Explain how adipose tissue contributes to chronic systemic and cutaneous inflammation.
- Explore the clinical relevance of metabolic pathways in dermatologic disease.
- Introduce incretin-based therapies and their emerging role in inflammatory skin conditions.
Segment 2: Lifestyle Strategies for Dermatology Practice (30 mins)
- Describe efficient methods for initiating lifestyle discussions during short dermatology visits.
- Provide practical examples of achievable diet and exercise recommendations.
- Discuss how to integrate lifestyle interventions into dermatologic care plans.
Sponsored by Lilly
THE SPEAKERS
We brought together medical experts that have devoted their time and energy to
advancing the field of integrative dermatology
Gary N. Harker
NON-CME MASTER CLASS
Safeguarding Wealth: Lawsuit Prevention and Tax Strategies1/21/25 | 5:00 PM PT
Martha Viera, MD
NON-CME MASTER CLASS
Topical Approach to Hair Health and Post-Procedure Care: Stem Cells and Naturally Derived Exosomes
Read Bio
2/25/25 | 5:00 PM PT
Cynthia Tie, MD
NON-CME MASTER CLASS
Topical Approach to Hair Health and Post-Procedure Care: Stem Cells and Naturally Derived Exosomes
Read Bio
2/25/25 | 5:00 PM PT
Asmi Berry , DO
NON-CME MASTER CLASS
Topical Approach to Hair Health and Post-Procedure Care: Stem Cells and Naturally Derived Exosomes
Read Bio
2/25/25 | 5:00 PM PT
Joseph Gretzula, DO FAAD
NON-CME MASTER CLASS
The power of Akkermansia and other novel probiotics: Supporting a holistic approach to beauty with targeted probiotic strains
Read Bio
1/14/25 | 5:00 PM PT
Christina O’Connor, RD
NON-CME MASTER CLASS
The power of Akkermansia and other novel probiotics: Supporting a holistic approach to beauty with targeted probiotic strains
Read Bio
1/14/25 | 5:00 PM PT
Eric Simpson, MD MCR
NON-CME MASTER CLASS
Navigating Atopic Dermatitis and Hand and Foot Dermatitis: Clinical Manifestations and Pathophysiology9/10/24 | 5:00 PM PT
April Armstong, MD MPH
NON-CME MASTER CLASS
Navigating Atopic Dermatitis and Hand and Foot Dermatitis: Clinical Manifestations and Pathophysiology9/10/24 | 5:00 PM PT
Victoria Werth, MD
NON-CME MASTER CLASS
Exploring Bullous Pemphigoid: Bridging Research and Clinical Practice10/22/24 | 5:00 PM PT
Kara Siedman, RD CDCES
NON-CME MASTER CLASS
Treating the Root Cause of Eczema: The Gut Microbiome Connection
Read Bio
11/5/24 | 5:00 PM PT
Sarina Elmariah, MD PhD
NON-CME MASTER CLASS
Scratching the Surface: Understanding Itch in Prurigo Nodularis8/13/24 | 5:00 PM PT
Teri M Greiling, MD PhD FAAD
NON-CME MASTER CLASS
Exploring Bullous Pemphigoid: Bridging Research and Clinical Practice10/22/24 | 5:00 PM PT
Raja Sivamani, MD MS AP
MASTER CLASSES AND LECTURES
Topical Approach to Hair Health and Post-Procedure Care: Stem Cells and Naturally Derived Exosomes
Read Bio
2/25/25 | 5:00 PM PST
Jason Hawkes, MD MS FAAD
NON-CME MASTER CLASS
Case-Based Learning: Difficult Psoriasis – Challenges from the Clinic
Read Bio
6/4/24 | 5:00 PM PST
Brennan Dedecker, ND
NON-CME MASTER CLASS
Elevate Your Membership: The Extraordinary World of Premium
Read Bio
3/12/24 | 5:00 PM PST
Raj Chovatiya, MD PhD MSCI FAAD
Tina Bhutan, MD MAS
NON-CME MASTER CLASS
Case-Based Learning: Difficult Psotiasis - Challenges from the Clinic
Read Bio
6/4/24 | 5:00 PM PST
Neal Bhatia, MD
MASTER CLASSES AND LECTURES
Case-Based Learning: Difficult Psotiasis - Challenges from the Clinic
Read Bio
6/4/24 | 5:00 PM PST
Ted Lain, MD MBA
NON-CME MASTER CLASS
Case-Based Learning: Difficult Psoriasis - Challenges from the clinic 6/4/24 | 5:00 PM PST
Read Bio
Julie Harper, MD
NON-CME MASTER CLASS
Non-CME
New Insights into Managing Acne Through a Novel Nutraceutical11/12/24 | 5:00 PM PST
Read Bio
New Insights into Managing Acne Through a Novel Nutraceutical11/12/24 | 5:00 PM PST
WATCH RECORDINGS
Catch Up on the Latest Advancements in Dermatology
Topical Approach to Hair Health and Post-Procedure Care: Stem Cells and Naturally Derived Exosomes
This webinar covers integrative approaches to hair health and recovery after aesthetic treatments like lasers, microneedling, and chemical peels. It highlights growth factor delivery and expert insights on advanced post-procedure care and innovations in hair restoration. Gain a comprehensive understanding of optimizing hair health and achieving better treatment outcomes.
Sponsored by NeoGenesis Inc.
Non-CME
The Power of Akkermansia and Other Novel Probiotics: Supporting a Holistic Approach to Beauty with Targeted Probiotic Strains
Discover the vital role of the gut microbiome, especially Akkermansia muciniphila, in natural GLP-1 production, weight management, and overall wellness. Join Dr. Joseph Gretzula and Christina O’Connor, RD, to explore how this microbe supports aesthetic goals. Learn actionable strategies to integrate gut health into your practice for a holistic approach to beauty and well-being.
Supported by Pendulum Therapeutics
Non-CME
Safeguarding Wealth: Lawsuit Prevention and Tax Strategies
Legally Mine will show you how to stop the threat of lawsuits before they ever get started by protecting your assets in time tested and proven legal structures. These same structures allow us to help our tax attorneys save what you would normally pay in income taxes. These are little known tax helps that have significant case history and have stood the test of time.
Sponsored by Legally Mine
Non-CME
New Insights into Managing Acne Through a Novel Nutraceutical
This master class discusses the evidence supporting the role of the six factors in the development of acne. It also presents clinical results from the use of a novel nutraceutical which addresses these root causes in subjects with non-cystic acne.
Non-CME
Treating the Root Cause of Eczema: The Gut Microbiome Connection
In this webinar, you’ll learn about the role Akkermansia muciniphila plays in the gut-skin axis and review case studies showing how addressing gut health can lead to effective treatments for eczema.
Non-CME
Exploring Bullous Pemphigoid: Bridging Research and Clinical Practice
Join experts Drs. Victoria Werth and Teri Greiling for an educational webinar about diverse clinical presentations, diagnostic challenges, and pathophysiology in BP.
Supported by ADVENT (Sanofi and Regeneron)
Non-CME
Navigating Atopic Dermatitis and Hand and Foot Dermatitis: Clinical Manifestations and Pathophysiology
Join experts Drs. Eric Simpson and April Armstrong at an ADVENT educational webinar where they will discuss the role of type 2 inflammation in atopic hand and foot dermatitis.
Sponsored by ADVENT (Sanofi and Regeneron)
NON-CME
Scratching the Surface: Understanding Itch in Prurigo Nodularis
Join experts Drs. Sarina Elmariah and Raja Sivamani at an educational ADVENT webinar as they unravel prurigo nodularis as an itchy dermatological condition. Uncover how clinical signs and itch in prurigo nodularis are impacted by type 2 inflammation. Discover diagnostic and management considerations for clinical practice. Sponsored by ADVENT (Sanofi and Regeneron)
NON-CME
Emerging and Novel Over-The-Counter Retinoids: Innovations in Dermatology
This masterclass will focus on a new retinoid ingredient Adapinoid and the emerging clinical evidence in comparison to retinol.
Supported by Actera
Non-CME
An Integrative Approach to Hormones and Stress in Dermatology
Join us for this master class to explore the intricate relationship between hormonal imbalances, stress, and skin health. Dermatological conditions often stem from internal factors such as hormonal fluctuations and psychological stressors, in addition to external influences.Supported by Codex Labs
Non-CME
Case-Based Learning: Difficult Psoriasis – Challenges from the Clinic
This webinar will review complex cases of psoriasis and psoriatic arthritis and discuss the clinical approach to diagnosis, selection of therapy, and comprehensive long-term management of the disease and overall patient care.
Supported by independent educational grants from Janssen Biotech, Inc and UCB
Non-CME
Chronic Hand Eczema
This lecture focuses on Chronic Hand Eczema (CHE), a persistent dermatological condition with significant implications on patient quality of life and psychological well-being. Leading dermatologist, Dr. Raj Chovatiya, presents current insights into the epidemiology, pathogenesis, diagnosis, and management of CHE.
Supported by LEO Pharma
Non-CME
Case-Based Learning: Difficult Psoriasis – Challenges from the Clinic
This webinar will review complex cases of psoriasis and psoriatic arthritis and discuss the clinical approach to diagnosis, selection of therapy, and comprehensive long-term management of the disease and overall patient care.
Supported by independent educational grants from Janssen Biotech, Inc and UCB
Non-CME
Chronic Hand Eczema
This lecture focuses on Chronic Hand Eczema (CHE), a persistent dermatological condition with significant implications on patient quality of life and psychological well-being. Leading dermatologist, Dr. Raj Chovatiya, presents current insights into the epidemiology, pathogenesis, diagnosis, and management of CHE.
Supported by LEO Pharma
Non-CME
Elevate Your Membership: The Extraordinary World of Premium
Premium membership has a lot to offer, and you might be wondering where to start? Join us as we explore key features of the LearnSkin platform and how to optimize the educational content and resources for your professional advancement and patient care. Discover exclusive perks available only to premium members and walk through cases using the new Natural Medicines Database (NMD) integration. Connect with like-minded colleagues and elevate your practice!
Non-CME
Psoriasis Case Discussions: Approach to All Disease Variants
This session will focus on case presentations featuring patients that have psoriasis and highlight our psoriasis and seborrheic dermatitis CME series.
Non-CME
Sign Up
You don't want to miss out on learning practical pearls to better help your patient's physical and mental health within dermatology.
WHO IS LEARNSKIN
LearnSkin is a dedicated group of dermatologists and integrative medicine practitioners with a mission to support professionals in dermatology. Their goal is to share the latest scientific research and treatment options in dermatology for both Western and Eastern medicine to meet the growing demand for responsible, quality, and evidence-based education bridging conventional and complementary medical approaches.
LearnSkin master classes, programs, and events are designed to provide clinicians like you with skills that expand past what was learned in school, residency, and traditional conferences with the hope you inspire change in your patients and reach better outcomes in their overall care.
Sponsor Prize
RAFFLE PRIZES
Attendees are automatically entered into a drawing to win a prize from LearnSkin or the dermatology webinar sponsor. You must attend live to be eligible and to claim your prize!
SPONSORS
ABBVIE
ACTIVE SKIN REPAIR
AYUSH HERBS
BIOCIDIN
CODEX LABS
DERMELEVE
DIAGNOSTIC SOLUSTIONS LAB
DUTCH TEST BY PRECISION ANALYTICAL
LILLY
REGENERON AND SANOFI
RESULTS RNA
Copyright 2023 © LearnHealth Inc. All rights reserved.